Oct 21, 2024 | 4 minute read
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, is showcasing its latest solutions in cardiology at the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting (October 27-30 in Washington D.C., USA). These cardiology innovations are designed to strengthen clinical confidence, enhance procedural efficiency and improve patient outcomes for interventional procedures – bringing better care to more people.
“With many exciting advancements on the horizon in cardiology, Philips is looking forward to connecting with our customers and partners at TCT and showcasing our latest suite of AI-enabled imaging systems, smart therapeutic and diagnostic devices, software, and services in integrated solutions,” said Stacy Beske, Business Leader for Image Guided Therapy Devices at Philips. “As a long-standing leader in the space, we are committed to harnessing the latest science and technology and working in collaboration with physicians to deliver best-in-class solutions to enhance patient care.”
As a long-standing leader in the space, we are committed to harnessing the latest science and technology and working in collaboration with physicians to deliver best-in-class solutions to enhance patient care.
The company’s latest technology advancements in diagnostic, interventional and monitoring solutions featured at TCT 2024 include:
Visit the Philips Engagement Hub (#2) where Philips will be providing more than 25 hours of physician-led educational content from lunch symposiums to a series of presentations and hands-on trainings across a variety of Philips cardiac solutions. Presentations will cover a range of image-guided therapy interventions, new advancements in technology and the use of artificial intelligence for minimally invasive procedures. For the full calendar of events, as well as general information about Philips’ presence at the show, visit the Philips website.
Visitors of the Philips booth at TCT can also see the power of the Philips X11-4t mini 3D TEE to support narrow spaces and complex cases to reach more of your patients. And access improved workflow with Recall Settings, which preserves and acquisition and imaging settings when switching between TEE and ICE.
Sources [1] 2024 ESC Guidelines for the management of chronic coronary syndromes. (European Heart Journal; 2024 – doi: 10.1093/eurheartj/ehae177)
[2] Gotberg M., Christiansen E.H., Gudmundsdottir I.J. Instantaneous wave-free ratio versus fractional flow reserve to guide PCI. N Engl J Med. 2017;376:1813–1823.
[3] Philips Laser System Data Sheet Specifications.
[4] Dippel et al. Randomized Controlled Study of Excimer Laser Atherectomy for Treatment of Femoropopliteal In-stent Restenosis: Initial ISR Results (2015). JACC 8(1): 92-101.